Details for New Drug Application (NDA): 075635
✉ Email this page to a colleague
The generic ingredient in ETOPOSIDE is etoposide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the etoposide profile page.
Pharmacology for NDA: 075635
Mechanism of Action | Topoisomerase Inhibitors |
Medical Subject Heading (MeSH) Categories for 075635
Suppliers and Packaging for NDA: 075635
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ETOPOSIDE | etoposide | CAPSULE;ORAL | 075635 | ANDA | Mylan Pharmaceuticals Inc. | 0378-3266 | 0378-3266-94 | 20 CAPSULE in 1 CARTON (0378-3266-94) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Sep 19, 2001 | TE: | RLD: | No |
Complete Access Available with Subscription